INCY:NASDAQ
Incyte Corp
$123.89
arrow_downward
-0.44%(-0.55) 1D
$123.89
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 25, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
$125.72
High
$126.00
Low
$123.07
Mkt. cap
25.11B
Avg. vol.
1.38M
Volume
1.21M
P/E ratio
15.79
52-wk high
$132.58
52-wk low
$81.79
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
Open
$125.72
High
$126.00
Low
$123.07
Mkt. cap
25.11B
Avg. vol.
1.38M
Volume
1.21M
P/E ratio
15.79
52-wk high
$132.58
52-wk low
$81.79
EPS
$7.85
Beta
0.77
Shares outstanding
202.70M
No. of employees
3K
News stories
From web sources and news partners
Business Wire
·
1 day ago
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva
Yahoo Finance
·
1 day ago
INCY, MIRM Slip Into FDA’s Weekend Decision Date On Shared Rare-Disease Pill
AD HOC NEWS
·
2 days ago
Incyte stock reports 38 percent revenue growth as shares trade at USD 123.47
AD HOC NEWS
·
2 days ago
Incyte stock heads into the open after a 1.23 percent drop
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com